T. Rowe Price Investment Management
KYMR icon

T. Rowe Price Investment Management’s Kymera Therapeutics KYMR Stock Holding History

T. Rowe Price Investment Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$34.6M Buy
2025
Q2 		$3.96M Buy
2024
Q1 		– Sell
2023
Q4 		$33M Sell
2023
Q3 		$22.4M Hold
2023
Q2 		$37M Sell
2023
Q1 		$58.3M Buy
2022
Q4 		$48.8M Sell
2022
Q3 		$43.5M Buy